Palliative chemotherapy outcomes in patients with ECOG-PS higher than 1

PURPOSE: Although patients with incurable disease and Eastern Cooperative Oncology Group performance status (ECOG-PS ≥ 2) are underrepresented in clinical trials, they are frequently offered palliative chemotherapy (pCT) in daily clinical practice in order to improve symptoms and quality of life. In...

Descripción completa

Detalles Bibliográficos
Autores principales: Caires-Lima, Rafael, Cayres, Karolina, Protásio, Bruno, Caires, Inacelli, Andrade, Júlia, Rocha, Lucila, Takahashi, Tiago Kenji, Hoff, Paulo M, de Castro, Gilberto, Mak, Milena Perez
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2018
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5931814/
https://www.ncbi.nlm.nih.gov/pubmed/29743951
http://dx.doi.org/10.3332/ecancer.2018.831

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5931814/
https://www.ncbi.nlm.nih.gov/pubmed/29743951
http://dx.doi.org/10.3332/ecancer.2018.831

Ejemplares similares